Predictive factors for a long-term response duration in non-squamous cell lung cancer patients treated with pemetrexed
2016
Background
Pemetrexed is widely used for the treatment of advanced non-squamous non-small-cell lung cancer (NSCLC). However, factors that can predict the benefits of pemetrexed therapy have not yet been defined.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
31
References
12
Citations
NaN
KQI